Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Schittenhelm

Showing results (11-20 of 226) with videos related to

Pageof 23
Sort By:
Cureus|July 8, 2025
Angiomatous, Predominantly Cystic Meningiomas: A Case Report and Literature Review of a Unique Group of MeningiomasCarmine Romano, Jens Schittenhelm, Marcos Tatagiba, et al.
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
International Journal of Surgical Pathology|May 8, 2013
Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltrationAzadeh Ebrahimi, Juergen Honegger, Hermann Schluesener, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2014
[Endocrine abnormalities in a patient with borderline personality disorder--case 8/2014]Christoph Gassenmaier, Jens Schittenhelm, Nadja Selo, et al.
Cells|July 26, 2024
Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical ImplicationsDavid Gorodezki, Martin U Schuhmann, Martin Ebinger, et al.
Endocrine Pathology|November 29, 2008
Symptomatic intraspinal oncocytic adrenocortical adenomaJens Schittenhelm, Florian H Ebner, Patrick Harter, et al.
Folia Neuropathologica|July 6, 2010
Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasmsJens Schittenhelm, Tsambika Psaras, Richard Meyermann, et al.
Biomedicines|June 26, 2026
Integrated Multi-Omics Analysis Reveals an HCMV-Associated Late-Gene Signature Associated with Poor Survival in Pediatric Group 3 MedulloblastomaMaria F Stierle, Martin U Schuhmann, Jens Schittenhelm, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2010
WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade of malignancyJens Schittenhelm, John Thiericke, Christoph Nagel, et al.
International Journal of Clinical and Experimental Pathology|December 1, 2015
IDH1 R132H mutation in a pilocytic astrocytoma: a case reportFelix Behling, Julia Steinhilber, Marcos Tatagiba, et al.
Pageof 23

Showing results (11-20 of 226) with videos related to

Sort By:
Pageof 23
Cureus|July 8, 2025
Angiomatous, Predominantly Cystic Meningiomas: A Case Report and Literature Review of a Unique Group of MeningiomasCarmine Romano, Jens Schittenhelm, Marcos Tatagiba, et al.
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
International Journal of Surgical Pathology|May 8, 2013
Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltrationAzadeh Ebrahimi, Juergen Honegger, Hermann Schluesener, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2014
[Endocrine abnormalities in a patient with borderline personality disorder--case 8/2014]Christoph Gassenmaier, Jens Schittenhelm, Nadja Selo, et al.
Cells|July 26, 2024
Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical ImplicationsDavid Gorodezki, Martin U Schuhmann, Martin Ebinger, et al.
Endocrine Pathology|November 29, 2008
Symptomatic intraspinal oncocytic adrenocortical adenomaJens Schittenhelm, Florian H Ebner, Patrick Harter, et al.
Folia Neuropathologica|July 6, 2010
Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasmsJens Schittenhelm, Tsambika Psaras, Richard Meyermann, et al.
Biomedicines|June 26, 2026
Integrated Multi-Omics Analysis Reveals an HCMV-Associated Late-Gene Signature Associated with Poor Survival in Pediatric Group 3 MedulloblastomaMaria F Stierle, Martin U Schuhmann, Jens Schittenhelm, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2010
WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade of malignancyJens Schittenhelm, John Thiericke, Christoph Nagel, et al.
International Journal of Clinical and Experimental Pathology|December 1, 2015
IDH1 R132H mutation in a pilocytic astrocytoma: a case reportFelix Behling, Julia Steinhilber, Marcos Tatagiba, et al.
Pageof 23